Gynecologic Cancer Foundation Company Profile

22:47 EDT 5th April 2020 | BioPortfolio

The Claudia Cohen Research Foundation is dedicated exclusively to support research leading to the immunological treatment, control, and prevention of gynecologic cancer with a special emphasis on gynecologic sarcoma.

News Articles [2736 Associated News Articles listed on BioPortfolio]

Prognostic Values of Platelet Parameters in Gynecological Tumors Patients

 Gynecologic cancers often involve the uterus, ovaries, cervix, vulva, vagina, fallopian tubes, or the peritoneum. The most common gynecologic cancer...

HRT of Menopausal Symptoms After Gynecologic Malignancy

This review focuses on the safety of hormone replacement therapy in women with a history of gynecologic cancer who have undergone surgery, chemotherapy, or radiation leading to early menopause. Meno...

The Mark Foundation funds projects at the intersection of AI and cancer research

(The Mark Foundation for Cancer Research) With these 8 projects, we are the first cancer research foundation now with a robust portfolio of grants in the artificial intelligence space.

Surgical Advances Improve QoL in Gynecologic Cancers

Mira Hellmann, MD, discusses surgical and systemic advancements in the field of gynecologic oncology.

National Foundation for Cancer Research conducts Salisbury Award Competition

(National Foundation for Cancer Research) The National Foundation for Cancer Research (NFCR) last Thursday, November 14, 2019, conducted its latest Salisbury Award Competition for Entrepreneurial Tran...

Prostate cancer screening study boosted by Movember & Alberta Cancer Foundation campaigns

(Nanostics) From the launch of Nanostics clinical validation study for ClarityDX Prostate, recruitment of men increased significantly in November, pushing the number of men enrolled over 200. This coi...

The Mark Foundation announces 2020 emerging leader awards

(The Mark Foundation for Cancer Research) The Mark Foundation for Cancer Research has awarded six grants to promising early career scientists for projects aimed at addressing unmet needs in cancer res...

Financial Toxicity Is Common With Gynecologic Cancers

More than one fifth of patients who are treated for gynecologic malignancies experience financial toxicity, results of a single-center study suggest. Medscape Medical News

Drugs and Medications [120 Associated Drugs and Medications listed on BioPortfolio]

No7 protect and perfect foundation sunscreen broad spectrum spf 15 calico [boots retail usa inc]


Meloxicam [kaiser foundation hospitals]

These highlights do not include all the information needed to use MELOXICAM TABLETS USP. safely and effectively. See full prescribing information for MELOXICAM TABLETS USP. MELOXICAM Tablets USP, for ...

Benzonatate [kaiser foundation hospitals]

Benzonatate Capsules, USP 100 mg

Gemcitabine hydrochloride [bluepoint laboratories]

These highlights do not include all the information needed to use Gemcitabine for Injection safely and effectively. See full prescribing information for Gemcitabine for Injection. Gemcitabine for inje...

Misoprostol [kaiser foundation hospitals]

Misoprostol Tablets 8204001/0613 Rx Only

PubMed Articles [6520 Associated PubMed Articles listed on BioPortfolio]

Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancer.

Women with gynecologic cancer may be at increased risk for adverse events (AEs) due to peritoneal disease burden and prior treatment (surgery, chemotherapy, and pelvic radiotherapy). This study compar...

Incidence and factors associated with venous thromboembolism in women with gynecologic cancer.

Venous thromboembolism (VTE) is a frequent clinical event in patients with gynecologic cancer. However, studies that exclusively address the incidence of VTE according the type of gynecologic cancer a...

GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE).

To explore whether patient-reported lymphedema-related symptoms, as measured by the Gynecologic Cancer Lymphedema Questionnaire (GCLQ), are associated with a patient-reported diagnosis of lymphedema o...

Hysterectomy and unilateral salpingectomy associate with a higher risk of subsequent ovarian cancer: A population-based cohort study in Taiwan.

Studies on the relationship between gynecologic surgery and subsequent ovarian cancer have been carried out in limited Western ethnic groups. We aim to evaluate whether receiving hysterectomy and/or s...

Reproductive and Hormonal Considerations in Women at Increased Risk for Hereditary Gynecologic Cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review.

Providers who care for women at risk for hereditary gynecologic cancers must consider the impact of these conditions on reproductive and hormonal health. This document reviews potential options for ca...

Clinical Trials [12416 Associated Clinical Trials listed on BioPortfolio]

Feasibility and Acceptability of a Yoga Intervention in Gynecologic Cancer

This study will test the feasibility and acceptability of a yoga program for women with gynecologic malignancies such as ovarian, endometrial, or cervical cancer. This study will pilot an ...

Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer

The aim of this study is to develop new tools using magnetic resonance imaging (MRI) that will improve the brachytherapy procedure and treatment for participants with gynecologic cancer.

A Self-Directed Mindfulness Meditation Intervention in Gynecologic Cancer Patients

The current study examines the effects of a 3-week, at-home mindfulness mediation intervention (MMI) to address psychological and physical distress in patients with gynecologic cancer.

Improving Sexual Health in Gynecologic Cancer Patients

This study seeks to find out if an early intervention of providing directed sexual health education and treatment for gynecologic cancer patients will improve patient outcomes as compared ...

Scalp Cooling in Gynecologic Cancer Patients

In gynecologic cancers, many common chemotherapy agents can lead to chemotherapy-induced alopecia. Currently t scalp cooling is the most well studied preventive measure. However, its accep...

Companies [2929 Associated Companies listed on BioPortfolio]

Gynecologic Cancer Foundation

The Claudia Cohen Research Foundation is dedicated exclusively to support research leading to the immunological treatment, control, and prevention of gynecologic cancer with a special emphasis on gyne...

The Claudia Cohen Research Foundation

The Claudia Cohen Research Foundation is dedicated exclusively to support research leading to the immunological treatment, control, and prevention of gynecologic cancer with a special emphasis on gyne...

The Gynecologic Cancer Foundation (based out of Chicago, IL)

OvaGene Oncology Inc.

OvaGene Oncology is a molecular diagnostics company, located in Orange County, California, dedicated to improving cancer care and outcomes for gynecologic cancer patients through the development of no...

Gynecologic Oncology Associates

Gynecologic Oncology Associates (GOA) is a group of Gynecologic Oncologists dedicated to the treatment of women with pelvic malignancies, precancerous conditions, and complex benign gynecologic condit...

More Information about "Gynecologic Cancer Foundation" on BioPortfolio

We have published hundreds of Gynecologic Cancer Foundation news stories on BioPortfolio along with dozens of Gynecologic Cancer Foundation Clinical Trials and PubMed Articles about Gynecologic Cancer Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gynecologic Cancer Foundation Companies in our database. You can also find out about relevant Gynecologic Cancer Foundation Drugs and Medications on this site too.

Quick Search

Relevant Topic

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record